New GERD drug shows symptom relief in large study
NCT ID NCT05660122
First seen Nov 01, 2025 · Last updated Apr 28, 2026 · Updated 17 times
Summary
This observational study enrolled 2,852 adults with erosive gastroesophageal reflux disease (GERD) to see if FEXUCLUE tablets improve symptoms like heartburn and regurgitation. Participants took the medication as prescribed by their doctor and reported their symptoms after 4 to 8 weeks. The study focused on patient-reported outcomes, not a cure, but aimed to ease discomfort.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROESOPHAGEAL REFLUX DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Samsung Medical Center
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.